Related Experiment Video
Updated: Jun 24, 2026

Spatiotemporal Control of Protein Activity through Optogenetic Allosteric Regulation
Published on: October 4, 2024
Reversion-induced LIM interaction with Src reveals a novel Src inactivation cycle
Yongjun Zhang1, Yizeng Tu, Jianping Zhao
1Department of Pathology, University of Pittsburgh, Pittsburgh, PA 15261, USA.
Abstract:
Aberrant Src activation plays prominent roles in cancer progression. However, how Src is activated in cancer cells is largely unknown. Genetic Src-activating mutations are rare and, therefore, are insufficient to account for Src activation commonly found in human cancers. In this study, we show that reversion-induced LIM (RIL), which is frequently lost in colon and other cancers as a result of epigenetic silencing, suppresses Src activation. Mechanistically, RIL suppresses Src activation through interacting with Src and PTPL1, allowing PTPL1-dependent dephosphorylation of Src at the activation loop. Importantly, the binding of RIL to Src is drastically reduced upon Src inactivation. Our results reveal a novel Src inactivation cycle in which RIL preferentially recognizes active Src and facilitates PTPL1-mediated inactivation of Src. Inactivation of Src, in turn, promotes dissociation of RIL from Src, allowing the initiation of a new Src inactivation cycle. Epigenetic silencing of RIL breaks this Src inactivation cycle and thereby contributes to aberrant Src activation in human cancers.
Insights
Reversion-induced LIM (RIL) normally suppresses Src activation in cancer. Epigenetic silencing of RIL disrupts this process, leading to uncontrolled Src activation and cancer progression.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- Aberrant Src activation is a key driver of cancer progression.
- The mechanisms of Src activation in cancer cells remain largely unclear.
- Genetic mutations alone do not fully explain common Src activation in cancers.
Purpose of the Study:
- To investigate the role of reversion-induced LIM (RIL) in regulating Src activation.
- To elucidate the molecular mechanisms by which RIL influences Src activity.
- To understand how RIL loss contributes to aberrant Src activation in cancer.
Main Methods:
- Investigated the interaction between RIL, Src, and PTPL1.
- Assessed the impact of RIL on Src dephosphorylation at the activation loop.
- Analyzed the effect of Src inactivation on RIL binding.
- Examined the role of RIL epigenetic silencing in cancer.
Main Results:
- RIL suppresses Src activation by facilitating PTPL1-dependent dephosphorylation.
- RIL preferentially binds to active Src, promoting its inactivation.
- Src inactivation leads to RIL dissociation, enabling new inactivation cycles.
- Epigenetic silencing of RIL disrupts this inactivation cycle, promoting aberrant Src activation.
Conclusions:
- RIL is a crucial component of a novel Src inactivation cycle.
- Loss of RIL through epigenetic silencing contributes to oncogenic Src activation.
- Targeting RIL or its pathway may offer therapeutic strategies for cancers with aberrant Src activation.
Related Concept Videos
Restarting Stalled Replication Forks
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Inheritance of Chromatin Structures
Inhibition of Cdk Activity
Inhibition of CDK Activity
